US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 2.920
  • 0.0000.00%
Close Mar 11 16:00 ET
  • 2.810
  • -0.110-3.77%
Post 17:16 ET
249.73MMarket Cap-1.46P/E (TTM)

About Atea Pharmaceuticals Company

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Company Profile

SymbolAVIR
Company NameAtea Pharmaceuticals
Listing DateOct 30, 2020
Issue Price24.00
Founded2012
CEODr. Jean-Pierre Sommadossi,PhD
MarketNASDAQ
Employees56
Fiscal Year Ends12-31
Address225 Franklin Street,Suite 2100
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-857-284-8891
Websitehttp://www.ateapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jean-Pierre Sommadossi,PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 5.93M
  • Wayne Foster
  • Executive Vice President, Finance and Chief Accounting Officer
  • 1.52M
  • Dr. Maria Arantxa Horga, M.D.
  • Chief Medical Officer
  • 1.85M
  • Andrea J. Corcoran
  • Chief Financial Officer, Executive Vice President, Legal and Secretary
  • 1.96M
  • John Vavricka
  • Chief Commercial Officer
  • --
  • Dr. Janet Hammond, M.D.,PhD
  • Chief Development Officer
  • 2.11M
  • Arthur Kirsch
  • Director
  • --
  • Jerome M. Ada M.D.
  • Independent Director
  • 442.10K
  • Dr. Polly A. Murphy, D.V.M.,PhD
  • Independent Director
  • 327.10K
  • Barbara G. Duncan
  • Independent Director
  • 332.10K
  • Dr. Bruce Polsky, M.D.
  • Independent Director
  • 324.60K
  • Bruno Lucidi
  • Independent Director
  • 324.60K
  • Franklin M. Berger, C.F.A.
  • Lead Independent Director
  • 357.10K

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Strategy
MSTR
260.590
Coinbase
COIN
191.690
Tesla
TSLA
230.580
4
Vale SA
VALE
9.400
5
Salesforce
CRM
277.050
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025